World News | S Korea: Prestige Biopharma Signs Sputnik Light Technology Transfer Contract
Get latest articles and stories on World at LatestLY. Prestige Biopharma announced that it has signed a technology transfer contract with HV (Human Vaccine), a subsidiary of the Russian Direct Investment Fund (RDIF), and ENSO (ENSO Healthcare DMCC), a Sputnik vaccine production partner, to produce Sputnik Light COVID-19 vaccine on the 5th.
Seoul [South Korea], November 9 (ANI/Global Economic): Prestige Biopharma announced that it has signed a technology transfer contract with HV (Human Vaccine), a subsidiary of the Russian Direct Investment Fund (RDIF), and ENSO (ENSO Healthcare DMCC), a Sputnik vaccine production partner, to produce Sputnik Light COVID-19 vaccine on the 5th.
The Sputnik Light is a single-dose COVID-19 vaccine developed by Russia.
Also Read | Google’s Parent Alphabet Market Value passes $2tn Mark.
Russia HV is a subsidiary of RDIF and has a license to produce and sell Sputnik vaccines. ENSO is an official partner in charge of procuring and distributing RDIF's Sputnik vaccine.
Prestige Biopharma explained, "This contract is a first stage of CMO production contract, and includes DS (Drug Substance) and DP (Drug Product) production technology transfer from Russia and validation."
Also Read | SpaceX Returns 4 Astronauts to Earth, Ending 200-day Flight.
Last month, Prestige Biopharma completed the construction of Campus 1 annex, which has commercial vaccine production facilities, in Osong, Chungcheongbuk-do.
It is also planning to complete a main vaccine center of Campus 2, which is currently under interior construction, within this year. Some of the 104,000 liters secured through these facilities will be allocated to the CMO production for HV and ENSO. The company said that the remaining production capacity is currently assigned to Sputnik V of Huons Global's Consortium.
This company is participating in the Huons Global Consortium as a supplier of Sputnik V vaccine DS. (ANI/Global Economic)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)